Technical Bulletins

About

The following technical bulletins are memos distributed to the UR Medicine Labs partners and affiliates. They are distributed via email and posted here for reference.

2026 Bulletins

• Immune Status Panel MMR/V IgG Antibody New Ordering Option Memo

2025 Bulletins

• Urine Microscopic Reporting Changes
• OPAST/GNFS Memo
• PTH -Calcium Group Test Memo
• New PCR Test for Detection of Measles Virus Memo
• Chemical dependency Screen Update Memo
• OGM Memo
• Protein Electrophoresis Report Updated Date Memo
• B27 Send Out Memo
• TIBC Updated Memo
• Oncomine Myeloid Assay Update Memo
• eRecord Changes: Bone Marrow for Lymphoma/Leukemia Workup (BMFLO)
• Microarray Testing Interim Change Memo
• New Test Profile: Extended CBC with Differential Memo
• Laboratory Information Systems (LIS) Update Memo
• eRecord Changes: Chromosome Analysis (CHRMS) FISH, CYTOGENETICS (FISHN) Memo
• eRecord Changes: Hold Green, Cytogenetics (CYGRN) Memo
• Solid Tumor NGS Panel: Resumption of In-House Testing and Change in Assay/Platform Memo
• Fecal Calprotectin and Fecal Pancreatic Elastase: New In-House Testing
• Primary HPV Testing Using Patient Collected Vaginal Swab Specimens
• Rapid Urea Medium for Detection of H. pylori
• Temporary Send out of MSI Testing and Solid Tumor Gene Panel Memo
• CLOtest Rapid Urease Test: Discontinued
• Chromosome Analysis (CHRMS) Memo
• Three Hour GTT Updated Criteria Memo
• HPV Reporting Changes Updated Effective Date Now 1.8.25
• Lead New Collection Option Memo

2024 Bulletins

• Lipid Panel LDL Cholesterol Calculation Update Memo
• TIBC/Transferrin Saturation Memo
• Strong West Urine Microscopic: New Orderable Test

• Cytology Service Interruption

• HPV Reporting Changes

• HSV-1/2 Quantitative NAAT, Plasma: New Test Memo

• POST CRTT Memo

• PCR B-Cell clonality testing: send out to ARUP

• TB Cell Subset- ARUP Memo

• Blood Gas Testing Changes Memo

• Cumulative Antibiograms for Community Outpatient Infections

• Interferon Gamma Release Assay New Test Platform

• Herpes Simplex Virus (HSV) Type 1&2 IgM: Test Discontinued
• Confirmation Barbiturates: Change in Testing Laboratory/Reportable Range
• Myeloid NGS Panel Change in Assay Platform
• Bone Marrow Engraftment Monitoring Chimerism Assay Kit Change
• CJD/Prion Markers: Delay in Testing for total Tau Protein Memo
• HLACD Risk Assessment Update Memo
• ImmunoCAP Allergy: New In-house Tree Nut Component Testing Memo
• New Lung Cancer Molecular Panel Memo
• HHV-6A/B Quantitative NAAT, Plasma: New test
• CBC/D Modernization and Simplification Memo
• MMRV Memo
• Heme Malignancy (NGSH) Panl Re-activated in eRecord
• Plasma Metanephrines: Increased Stability Time and Room Temperature Shipping
• Celiac EBV Serology Memo
• UNGAL Testing in Urine: New In House Test

2023 Bulletins

• Hemolysis Interference Update Memo
• Pediatric GFR Equation Update Memo
• Updated Names for Testosterone Orders
• Molecular Test Reporting Changes
• Discontinuation of Caffeine Testing Memo
• HIV-1/2 Qualitative NAAT Memo
• Fondaparinux (Aristra) Anti-Xa-Cessation of Testing Memo
• DD Stability Increase Memo
• Change in ordering EGFR, KRAS and NRAS
• Collection and Transport of Urine for Culture and Urinalysis
• CEBPA Memo
• Celiac tTG DGP Memo
• CBCD Reference Ranges Memo 
• Changes to Flow Cytometry
• TSH Reflex to Free T4 Memo
• DAU Memo
• Microarray Memo
• RHIO Downtime Notification
• ImmunoCAP Allergy: Peanut Components Memo
• Change in Folate Testing Lab
• Alcohol Panel Update
• Buprenorphine Change in Testing Lab
• Hemolysis Interference Update

2022 Bulletins

• Total/Free and Total Testosterone Orders Updated Options Memo
• Reticulocyte Count Update Memo
• Solid Tumor Next Generation Sequencing Delays
• Factor X Chromogenic Testing Discontinuation Memo
• Interferon Gamma Release Assay: Rebuilt
• Molecular Delays Memo
• Blood Bank Testing-Updated Specimen Tube Type (Revised)
• Apixaban Memo
• Tacrolimus and Cyclosporine Memo
• Pathology Delays
• BK Virus Quantitative NAAT Change to Assay
• Blood Lead Capillary and Venous Memo
• Blood Bank Testing-Updated Tube Type
• Adenovirus Quantitative NAAT New Test Memo 
• UCDS Memo
• Lyme Testing Guidance for Healthcare Providers
• Anti-HBclgM Memo
• ImmunoCAP Interpretation Memo
• eGFR Updated Calculation Memo
• hsTnT Memo
• HPV Memo

2021 Bulletins

• Post-Vasectomy Semen Analysis: SMH ONLY
• Change to C. difficile Testing Algorithm
• Maternal Screen Testing: Change in Testing Laboratory
• Rheumatoid Factor with Reflex to Titer: Change to Assay
• Streptolysin O Antibody (ASO) Return to In House Testing
• Epstein-Barr Virus (EBV) Quantitative PCR, Plasma New Assay
• BCR-ABL1 Major Quantitavie Testing
• APIA PPIA Testing Now Available
• Meningitis Encephalitis PCR Panel: Temporarily Limited Panel
• BCR-ABL1 Quantitative Testing
• Cystatin C: New Test In-House
• Streptolysin O Antibody (ASO) Temporary Change to Turn-around Time
• Microarray 044k Discontinued Test
• PathDelays
• QuantiFERON TB Analyzer: Delay in Testing
• SARS-CoV-2 Antibody (IgG), Spike Protein
• Urine ETG: Change in Performing Laboratory
• Critical Shortage of Blue-Top Blood Collection Tubes-Suspension of Testing
• Immunotyping: Addition of Testing Platform
• Citrate Tube Critical Shortage Notification
• Critical Glucose Update for Newborns
• Positive Bias for Creatinine Results
• C-Reactive Protein (CRP): New Reference Range
• Random High Sensitivity Troponin: Expansion of Testing
• Euglobulin Clot Lysis Time: Cessation of Testing 
• Homocysteine: Change in Specimen Requirements
• Aspirin Platelet Inhibition - Collection Tube Shortage
• QuantiFERON TB Analyzer: Delay in Testing
• Meningitis Encephalitis PCR Panel: Resume In-House Testing
• CMV Virus Testing for Neonatal Samples: Return to on-site testing
• Urine Ethyl Glucuronide: Change in Performing Laboratory
• Molecular Diagnostics Testing: Change in Performing Laboratory

2020 Bulletins

• CMV Virus Testing for Neonatal Samples: Reagent Shortage

• Microsatellite Instability (MSI): New Molecular Diagnostics Test

• Meningitis Encephalitis PCR Panel: Reagent Shortage

• Epstein Barr Virus (EBV) Serology: Change to Assay

• Urine Ethyl Glucuronide: Change in Performing Laboratory

• Coagulation Testing: Updated Reference Ranges

• COVID-19 Testing: New Reporting Requirements

• Serum Free Light Chains Assay: Change to Testing Platform

• Urinalysis: Change in Testing Platform

• Semi-Quantitative THC: Change in Testing Methodology

• Allergy Testing: Change in Specimen Storage Policy

• SARS-CoV-2 Antibody (IgG) Testing: New Assay

• Urine Ethyl Glucuronide: Change in Performing Laboratory

• Urine Drug Confirmation Testing: Change in Performing Laboratory

• Buprenorphine Testing: Update to Assay

• COVID19 Testing Guidelines for Healthcare Providers

• Procalcitonin: Change to Testing Platform

• 2019 Novel Coronavirus: Guidelines for Patients Under Investigation

• Heparin-Induced Thrombocytopenia (HITAB): Update to Testing

• Cryptococcal Antigen: Change to Assay

2019 Bulletins

• New CMS Regulations Regarding Molecular Pathology

• Mycoplasma genitalium NAAT on genitourinary specimens: New Assay

• BHCG Tumor Marker: New Assay

• Urine Drug Screenings: Testing Updates

• Vitamin D Testing: Change to Assay

• Vitamin D: Delay in Testing

• Saliva Cortisol Testing: Temporary Change in Performing Laboratory

• Urine Drug Confirmation Testing: Temporary Change in Performing Laboratory

• Meningitis and Encephalitis Panel: New Assay

• Chlamydia (PDC) and Gonorrhoeae (PDG) Testing: Change to Assay

• Chromosome Microarray (MaCGH) Laboratory Testing

• New CMS Regulations Regarding Molecular Pathology

• Patient Service Center Hours of Operation Notice

• Detection of Viral Pathogens in Stool: Change to Assay

• Maternal Screen Testing: Temporary Change in Testing Laboratory

• Complete (comprehensive) Semen Analysis Panel: Change to Testing

• Molecular Diagnostics Laboratory Testing

• UR Medicine Laboratory Relocation Project

• Urine Hemosiderin: Change in Performing Laboratory

• Total Iron Binding Capacity (TIBC): Change in Methodology

• Required regulatory information: Immunophenotyping by Flow Cytometry

• Lyme Disease Antibody Testing: Change to Assay

• Congenital Cytomegalovirus (CMV): New Assay

• High Dose Biotin May Interfere with Lab Tests

• Urinalysis reflex testing (UAR and UARWC): New Reflex Criteria

• Glucose: Critical Value Change

• Magnesium (Mg) and Creatine Kinase (CK): Change in Reporting

2018 Bulletins

• Anti-Cardiolipin (aCL) IgG/IgM and Beta-2 Glycoprotein I (aB2GPI) IgG/IgM: Change to Assay

• Buprenorphine Test for UR Medicine Emergency Departments

• Fentanyl: Change in Screening

• Anti Mullerian Hormone Assay

• Elution Swabs™ (ESwabs) for Bacterial and Fungal Culture

• Chlamydia/GC/Trichomonas PCR Platform Change

• Hemoglobin A1c: Change in Assay

• Virus-Specific PCR Tests Replacing Viral Culture 

• Respiratory Viruses testing

• Measles or Mumps viruses by PCR

• Creatine Kinase MB (CK-MB): Change in Testing

• QuantiFERON® TB (M.Tuberculosis exposure): Change in Testing

• Thyroglobulin and Related Antibodies: Notification of Assay Changes
• Anti-Cyclic Citrillinated Peptide (CCP) IgG: Change to Assay
• Chlamydia, Gonorrhoeae, and Trichomonas Test Delays
• ROMA (Risk of Ovarian Malignancy Algorithm)
• New High Sensitivity (HS) Troponin Assay
• Thromboelastography Testing (TEG): Critical Values
• BD Affirm Collection and Transport System for Triple Screen
• HSV-1 and HSV-2 Type Specific IgG Antibodies: Change to Assay
• Hemoglobin Electrophoresis Consent
   

Older Bulletins